AudioAbstracts by ReachMD provides an easy-to-digest distillation of important medical literature in combination with digital linkage to in-depth information supporting the audio synopsis. AudioAbstracts harnesses the ReachMD digital network to broadcast the spoken synopsis and related digital links through its on-air, online, onsite, and mobile distribution network. Combining quick-read audio synopses with links to source material, AudioAbstracts is the smarter, faster way to stay current on medical literature.

Podcast Authority
Beta
Podcast Overview
AudioAbstracts by ReachMD provides an easy-to-digest distillation of important medical literature in combination with digital linkage to in-depth information supporting the audio synopsis. AudioAbstracts harnesses the ReachMD digital network to broadcast the spoken synopsis and related digital links through its on-air, online, onsite, and mobile distribution network. Combining quick-read audio synopses with links to source material, AudioAbstracts is the smarter, faster way to stay current on medical literature.
Language
🇺🇲
Publishing Since
9/4/2015
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for AudioAbstracts
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

June 26, 2026
Exploring Deeper Silencing in Transthyretin Amyloidosis
Guest: Ryan Quigley <br> <p>New real-world data are reshaping the conversation around transthyretin suppression in transthyretin amyloidosis. In this <i>AudioAbstract</i>, Ryan Quigley explains how a crossover analysis revealed substantially deeper serum transthyretin suppression with vutrisiran than patisiran, raising important questions about whether more complete silencing could influence long-term outcomes. </p>

June 26, 2026
How Symptoms Shape Caregiver Burden in ATTR-CM
Host: Ryan Quigley <br> <p>New findings from a post hoc analysis of the Burden of Disease survey highlight how symptom severity and loss of independence in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) contribute to increased caregiver burden, fatigue, anxiety, and depression. In this <i>AudioAbstract, </i>Ryan Quigley discusses which patient-reported symptoms and limitations were most strongly associated with distress and explains why preserving mobility and functional independence may be critical to improving outcomes for both patients and caregivers.</p>

March 30, 2026
Rebalancing Amyloid in ATTR-CM: Emerging Therapeutic Insights
Host: Hallie Blevins, PhD <br> <p>While transthyretin amyloid cardiomyopathy (ATTR-CM) is often viewed solely as a disorder of protein misfolding, a new review published in the <i>European Heart Journal </i>presents it as a dynamic imbalance between amyloid production and clearance. Hear from Dr. Hallie Blevins as she reviews pivotal data on ATTR-CM's expanding therapeutic landscape.</p>
49 total episodes available
Deep-dive analytics for AudioAbstracts
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is AudioAbstracts?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.